Last reviewed · How we verify
NCT06827665: JUH
Clinical and Radiographic Evaluation of Allogenic Dentin Grafts for Alveolar Ridge Preservation
Phase 1, PHASE2 trial testing DDA in Alveolar Ridge Preservation in 10 participants. Currently enrolling.
30 January 2027
Quick facts
| Lead sponsor | Jordan University Hospital |
|---|---|
| Phase | Phase 1, PHASE2 |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 10 |
| Start date | 1 January 2025 |
| Primary completion | 30 January 2027 |
| Estimated completion | 30 December 2027 |
| Sites | 1 location across Jordan |
Drugs / interventions tested
Conditions studied
- Alveolar Ridge Preservation — all drugs for Alveolar Ridge Preservation →
Sponsor
Jordan University Hospital
Who can join
Adults 18 to 60, any sex, with Alveolar Ridge Preservation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
For the first time, allografts from human-extracted teeth will be prepared and evaluated in a prospective clinical trial to assess their efficacy for alveolar ridge preservation. The reconstruction and preservation of the alveolar ridge after tooth extraction are essential for future prosthetic rehabilitation. Autogenous bone grafts, while effective, are limited by donor site morbidity and insufficient graft quantity. Allogenic dentin grafts from healthy human donors present a scalable solution. This study aims to evaluate the biocompatibility and effectiveness of two types of allogenic dentin grafts-demineralized dentin allografts (DDA) and whole tooth allografts (WTA)-for alveolar ridge preservation, contributing to innovative, sustainable dental practices.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06827665
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Alveolar Ridge Preservation
Currently open trials in the same condition.
- NCT07242313 — Comparison of Demineralized and Mineralized Dentin Grafts in Ridge Preservation · NA · recruiting
- NCT07526129 — Impact of Alveolar Ridge Preservation on the Potential Need for Sinus Floor Elevation: A 10-year Retrospective Radiograp · recruiting
- NCT06784232 — Alveolar Ridge Preservation: Biologically-oriented Alveolar Ridge Preservation Vs Modified Periosteal Inhibition · active not recruiting
- NCT06141239 — 2D/3D Imaging to Analyze the Regeneration Rate of Autologous Bone · NA · recruiting
- NCT06970184 — Alveolar Ridge Preservation With Cortico-cancellous Porcine Bone · active not recruiting
Other Jordan University Hospital trials
Trials by the same sponsor.
- NCT05205707 — Association of Circulating ACE2 Levels With COVID-19 · completed
- NCT04980170 — Clindamycin Versus Amoxicillin With Clavulanic Acid in Prevention of Early Dental Implants Failure · EARLY_PHASE1 · unknown
- NCT05375058 — Complicated Appendicitis During the COVID-19 Pandemic in Jordan · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06827665 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Jordan University Hospital
- Last refreshed: 14 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06827665.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing